Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

280
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
280
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

275
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
275
Long-term Depression01:05

Long-term Depression

31.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.0K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

176
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
176
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

140
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
140

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building independent mental health practice through collaborative care.

Academic pediatrics·2026
Same author

Test of the reward/circadian rhythm dysregulation model of risk for bipolar spectrum disorders at a micro time scale using multilevel moderated mediation.

Journal of psychopathology and clinical science·2026
Same author

US Emergency Department Use and Operations Amid Natural Disasters: A Narrative Review.

The western journal of emergency medicine·2026
Same author

Domain-specific circadian rescue following sleep deprivation.

Sleep·2026
Same author

Epigenetic Responses to Abusive versus Accidental Injuries in Children: A Cross-sectional Epigenome Wide Association Meta-analysis.

medRxiv : the preprint server for health sciences·2026
Same author

Communication Regarding Mental Health Between Pediatric Healthcare Providers and K-12 School Staff: A Scoping Review.

The Journal of school health·2026

Related Experiment Video

Updated: Jul 21, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.7K

Light Therapy for Adolescent Depression: A Scoping Review.

Rachel Ballard1, John Parkhurst1, Kelsey Julian1

  • 1Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E. Chicago Ave, Box 10, 60611, Chicago, IL, USA.

Current Psychiatry Reports
|July 25, 2023
PubMed
Summary

Bright Light Therapy (BLT) shows promise for adolescent depression. More research is needed to confirm its effectiveness and suitability for young people, building on adult studies.

Keywords:
AdolescentBright light therapyChronotherapyMajor depressionPediatricsSeasonal affective disorder

More Related Videos

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:03

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

454
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.3K

Related Experiment Videos

Last Updated: Jul 21, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.7K
Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:03

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

454
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.3K

Area of Science:

  • Psychiatry
  • Adolescent Medicine
  • Mental Health Treatment

Background:

  • Adolescent depressive disorders pose significant risks to development, social integration, and education.
  • Bright Light Therapy (BLT) is an established treatment for adult depression, but its use in adolescents is less explored.
  • Existing research highlights the need for more controlled trials in pediatric populations.

Purpose of the Study:

  • To conduct a scoping review on the current knowledge of Bright Light Therapy (BLT) for treating depression in adolescents.
  • To identify novel data and methodological approaches in BLT research for pediatric and young adult populations.
  • To assess the feasibility and effectiveness of BLT in adolescent depression.

Main Methods:

  • Literature search for studies on Bright Light Therapy (BLT) in adolescent depression.
  • Review of novel data and methodological advancements in pediatric BLT research.
  • Analysis of existing evidence regarding BLT's tolerability and side effect profile.

Main Results:

  • Bright Light Therapy (BLT) is generally well-tolerated with minimal side effects in adolescent populations.
  • There is a significant lack of well-powered studies evaluating BLT efficacy for adolescent depressive disorders.
  • Evidence from adult studies suggests potential benefits, warranting further investigation in adolescents.

Conclusions:

  • Bright Light Therapy (BLT) is a potentially viable treatment option for adolescent depression.
  • Further research is crucial to establish the efficacy, feasibility, and acceptability of BLT in adolescents.
  • Well-designed, controlled trials are needed to support the use of BLT for adolescent depression.